Northwestern, AbbVie partner to research cancer therapies
A new collaboration between two Chicago healthcare entities will provide a platform to conduct ongoing cancer research.
AbbVie and Northwestern University have agreed to a five-year collaboration in which Northwestern’s Lurie Cancer Center will be able to access new therapies made by AbbVie. The collaboration will focus on lung, colorectal, breast, prostate and blood cancers, according to a recent report from Crain’s Chicago Business.
In addition to working with Northwestern, AbbVie has announced similar collaborations with Johns Hopkins University School of Medicine in Baltimore and the University of Chicago.
To read more about the partnerships, follow the link below:
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.